RU93004785A - SOLID CAPSULES OF CITARABIN OXPHOSPHATE - Google Patents

SOLID CAPSULES OF CITARABIN OXPHOSPHATE

Info

Publication number
RU93004785A
RU93004785A RU93004785/14A RU93004785A RU93004785A RU 93004785 A RU93004785 A RU 93004785A RU 93004785/14 A RU93004785/14 A RU 93004785/14A RU 93004785 A RU93004785 A RU 93004785A RU 93004785 A RU93004785 A RU 93004785A
Authority
RU
Russia
Prior art keywords
capsules
cytarabine
oxphosphate
citarabin
solid
Prior art date
Application number
RU93004785/14A
Other languages
Russian (ru)
Other versions
RU2116069C1 (en
Inventor
Аоки Минору
Охтаки Хироси
Накада Минору
Фукуи Нобухару
Терада Такаси
Original Assignee
Ниппон Каяку Кабусики Кайся
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ниппон Каяку Кабусики Кайся filed Critical Ниппон Каяку Кабусики Кайся
Publication of RU93004785A publication Critical patent/RU93004785A/en
Application granted granted Critical
Publication of RU2116069C1 publication Critical patent/RU2116069C1/en

Links

Claims (1)

Изобретение относится к твердым капсулам окфосфата цитарабина, которые предназначены для использования в качестве антилейкемических лекарственных препаратов, применяемых перорально. Твердые капсулы окфосфата цитарабина включают окфосфат цитарабина, высокомолекулярное вещество, функционирующее как разрыхлитель, и щелочной агент. Эти твердые капсулы представляют собой фармацевтический препарат, имеющий прекрасную распадаемость и стабильность. Твердые капсулы окфосфата цитарабина предлагаются к клиническому использованию.The invention relates to cytarabine solid phosphate capsules, which are intended for use as anti-leukemic drugs, administered orally. Cytarabine solid phosphate capsules include cytarabine phosphate, a high molecular weight substance functioning as a disintegrant, and an alkaline agent. These hard capsules are a pharmaceutical preparation that has excellent disintegration and stability. Cytarabine solid phosphate capsules are offered for clinical use.
RU93004785A 1992-04-03 1993-04-02 Cytarabine ocphosphate solid capsule RU2116069C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP04-109053 1992-04-03
JP10905392 1992-04-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU04109053 Division 1992-04-03

Publications (2)

Publication Number Publication Date
RU93004785A true RU93004785A (en) 1996-06-20
RU2116069C1 RU2116069C1 (en) 1998-07-27

Family

ID=14500416

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004785A RU2116069C1 (en) 1992-04-03 1993-04-02 Cytarabine ocphosphate solid capsule

Country Status (14)

Country Link
US (1) US5512298A (en)
EP (1) EP0563697B1 (en)
KR (1) KR100267525B1 (en)
CN (1) CN1039673C (en)
AU (1) AU657044B2 (en)
BR (1) BR9301373A (en)
CA (1) CA2093258C (en)
CZ (1) CZ282844B6 (en)
DE (1) DE69330392T2 (en)
ES (1) ES2160582T3 (en)
HU (1) HU217810B (en)
PL (1) PL171011B1 (en)
RU (1) RU2116069C1 (en)
TW (1) TW266160B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080138437A1 (en) * 2004-02-09 2008-06-12 Shuji Sakuma Antitumor Agent
US7576216B2 (en) 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
EP1872798B1 (en) * 2005-04-06 2013-06-05 Kabushiki Kaisha Sangi Intestinal absorptive anti-tumor agent
WO2006110815A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
RU2657833C2 (en) 2015-12-01 2018-06-15 Общество С Ограниченной Ответственностью "Остерос Биомедика" Stabilized dosage form of etidronate-cytarabine conjugate and its application
EA030671B1 (en) 2016-07-20 2018-09-28 Общество С Ограниченной Ответственностью "Остерос Биомедика" Preparation for treating bone lesions caused by malignant neoplasms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859431A (en) * 1973-01-04 1975-01-07 Lilly Industries Ltd Drug formulations
JPS552601A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd Anti-tumor agent for non-injection use
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
EP0239015B1 (en) * 1986-03-24 1991-10-16 Nippon Kayaku Kabushiki Kaisha Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5223503A (en) * 1991-04-29 1993-06-29 Eli Lilly And Company 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents

Similar Documents

Publication Publication Date Title
CA2307018A1 (en) Osmotic medicament releasing system
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
HUP9802339A2 (en) Pharmaceutical formulations containing darifenacin
IE871584L (en) Sustained release capsule.
ATE209898T1 (en) SOLID MEDICINAL PREPARATION
HUP0204110A2 (en) Amphiphilic prodrugs, process for preparation and use of pharmaceutical compositions containing them
HUP0004383A2 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
CA2386690A1 (en) Pharmaceutical tramadol salts
HUP0003323A2 (en) Pharmaceutical formulations containing voriconazole
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
HUP0000587A1 (en) Pharmaceutical composition containing tacrolimus (fk506)
EA199900734A1 (en) MICROCAPSULES CONTAINING CIS-PLATIN
KR850700212A (en) Sustained Release Pharmaceutical Wexel
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
RU93004785A (en) SOLID CAPSULES OF CITARABIN OXPHOSPHATE
US3284298A (en) Analgetic compositions and methods
CA2093258A1 (en) Cytarabine ocfosfate hard capsule
GEP20043377B (en) Pharmaceutical Complex
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
RU93047049A (en) NEW PHOSPHOLIPIDES DERIVATIVES
ES2384715T3 (en) 4 - [[4 - [[4- (2-Cyanoetenyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile fumarate
GB9420748D0 (en) 1,5 benzodiazepine derivatives